Key takeaways:
- Most patients used the iCare Home2 device multiple times per day.
- The device captures daily IOP fluctuations that occur outside the office.
IOP measurements taken at home with the iCare Home2 tonometer correlated closely with in-office measurements, according to a study published in Clinical Ophthalmology.
Most patients used the device multiple times per day, with significant swings in IOP occurring outside of clinic hours.
IOP measurements taken at home with the iCare Home2 tonometer correlated closely with in-office measurements.
“In-office IOP monitoring provides only limited IOP surveillance, missing clinically relevant peaks and fluctuations that occur outside of office hours or from day to day,” Scott W. Perkins, a medical student at Cleveland Clinic Lerner College of Medicine, and colleagues wrote. “The iCare Home rebound tonometer was developed and FDA-approved for patient home self-use, enabling over 75% of trained patients to take home IOP measurements that are accurate when compared to Goldmann applanation tonometry.”
Read more: https://rb.gy/d1ulig
Source: Healio